STOCK TITAN

Major holders of Aesthetic Medical (PAIYY) update 37.6% stake and JV structure

Filing Impact
(High)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13D/A

Rhea-AI Filing Summary

Aesthetic Medical International Holdings Group Ltd’s major investors have updated their ownership disclosure in Amendment No. 3 to a Schedule 13D. MY Universe (HK) Limited and affiliated entities report beneficial ownership of 36,402,570 ordinary shares, representing 23.7% of the company’s ordinary share capital.

Suqian Beibao Culture Communication Co., Ltd. and Suqian Baibao Technology Co., Ltd. are tied to this same 23.7% stake through My Universe. Individually, ZHENG Qingying and WU Guiqian each report shared beneficial ownership of 57,815,846 ordinary shares, or 37.6% of the class, through interests in My Universe and Hawyu (HK) Limited.

The filing also details a series of historic agreements, including a 36,402,570-share subscription and a 21,321,962-share purchase, and describes recent Subscription and Partnership Withdrawal Agreements that reshaped the partner structure of Jiechuang. Several entities will cease to be reporting persons, while the remaining investors state they will continue to review their investment and potential strategic alternatives.

Positive

  • None.

Negative

  • None.
MY Universe stake 36,402,570 ordinary shares Beneficially owned; 23.7% of Aesthetic Medical ordinary shares
Zheng & Wu shared stake 57,815,846 ordinary shares Shared beneficial ownership; 37.6% of ordinary share class
Shares outstanding 147,326,504 ordinary shares Issued and outstanding used to compute ownership percentages
Wanda warrant shares 6,423,983 ordinary shares Ordinary shares issuable under warrants granted to Wanda
Jiechuang subscription 36,402,570 shares for RMB170,000,000 Newly issued ordinary shares subscribed via Share Subscription Agreement
Wanda share purchase 21,321,962 shares for RMB100,000,000 Ordinary shares purchased from sellers under Share Purchase Agreement
Note conversion price RMB4.203 per ordinary share Conversion price for ADV Note principal and catch-up amount
Warrant exercise price RMB4.67 per ordinary share Exercise price for ADV warrant to purchase ordinary shares
Share Subscription Agreement financial
"entered into a Share Subscription Agreement (the "Jiechuang Agreement") whereby Jiechuang or its designated entity agrees"
A share subscription agreement is a written contract in which an investor agrees to buy a specific number of a company's shares at an agreed price and under stated conditions. It matters to investors because it spells out who pays what, when shares are issued, and any protections or obligations for both sides—like a detailed purchase order that clarifies ownership, timing and potential dilution risk so investors know exactly how their stake will be created and protected.
Share Purchase Agreement financial
"entered into a Share Purchase Agreement (the "Wanda Agreement") whereby Wanda agrees to purchase"
A share purchase agreement is a written contract that outlines the terms and conditions for buying and selling shares of a company. It specifies details like the price, number of shares, and any special conditions, ensuring both buyer and seller agree on the transaction. For investors, it provides clarity and legal protection, making sure the purchase is clear and enforceable.
Cooperation Agreement financial
"entered into a Cooperation Agreement (the "Cooperation Agreement"). Pursuant to the Cooperation Agreement, ADV shall"
A cooperation agreement is a formal contract between two or more organizations that lays out who will do what, how resources and responsibility are shared, how benefits or costs are divided, and how disputes or exits are handled. Like two chefs agreeing on a shared recipe and kitchen duties, it matters to investors because it can create new revenue paths, shift costs or risks, affect who controls key assets or technologies, and change a company’s future growth prospects.
Voting Support Agreement financial
"entered into a Voting Support Agreement (the "Voting Support Agreement", together with the Jiechuang Agreement"
A voting support agreement is a written promise by major shareholders or stakeholders to vote their shares a specific way on a planned corporate action, such as a merger or management slate. It matters to investors because it increases the likelihood that the action will pass — like a group of neighbors agreeing in advance to back a local project — which reduces deal uncertainty but can also concentrate control and limit minority influence.
Subscription Agreement financial
"entered into a Subscription Agreement and Admission Agreement (the "Subscription Agreement"). Pursuant to the Subscription Agreement"
A subscription agreement is a legal contract in which an investor agrees to buy a specific number of a company’s shares or other securities under set terms, including price, payment method and conditions for closing the sale. It matters to investors because it legally locks in their purchase and the company’s obligations, determines ownership percentage and any investor rights, and can include conditions or promises that affect future control or returns—like signing a detailed purchase order for equity.
Partnership Withdrawal Agreement financial
"entered into a Partnership Withdrawal Agreement (the "Withdrawal Agreement") with respect to Jiechuang"
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





00809M104

(CUSIP Number)
Ningxin Sun, Esq.
Charles Wilson LLP, Unit 1601, 100QRC, 100 Queen's Road Central, Central
Hong Kong, F4, 000000
852 9565 6373

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)
03/26/2026

(Date of Event Which Requires Filing of This Statement)


If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).




schemaVersion:


SCHEDULE 13D




Comment for Type of Reporting Person:
For rows 7 and 9, represent 36,402,570 ordinary shares directly beneficially owned by MY Universe (HK) Limited. For row 13, the percentage of the class of securities beneficially owned by each Reporting Person is calculated based on 147,326,504 issued and outstanding ordinary shares of the Issuer and 6,423,983 ordinary shares issuable under the warrants granted to Wanda as of the date of this Amendment No. 3 to the Schedule 13D.


SCHEDULE 13D




Comment for Type of Reporting Person:
For rows 7 and 9, represent 36,402,570 ordinary shares directly beneficially owned by MY Universe (HK) Limited. For row 13, the percentage of the class of securities beneficially owned by each Reporting Person is calculated based on 147,326,504 issued and outstanding ordinary shares of the Issuer and 6,423,983 ordinary shares issuable under the warrants granted to Wanda as of the date of this Amendment No. 3 to the Schedule 13D.


SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D




Comment for Type of Reporting Person:
For rows 7 and 9, represent 36,402,570 ordinary shares directly beneficially owned by MY Universe (HK) Limited. For row 13, the percentage of the class of securities beneficially owned by each Reporting Person is calculated based on 147,326,504 issued and outstanding ordinary shares of the Issuer and 6,423,983 ordinary shares issuable under the warrants granted to Wanda as of the date of this Amendment No. 3 to the Schedule 13D.


SCHEDULE 13D




Comment for Type of Reporting Person:
For rows 7 and 9, represent 36,402,570 ordinary shares directly beneficially owned by MY Universe (HK) Limited. For row 13, the percentage of the class of securities beneficially owned by each Reporting Person is calculated based on 147,326,504 issued and outstanding ordinary shares of the Issuer and 6,423,983 ordinary shares issuable under the warrants granted to Wanda as of the date of this Amendment No. 3 to the Schedule 13D.


SCHEDULE 13D




Comment for Type of Reporting Person:
For rows 8 and 10, represent 36,402,570 ordinary shares indirectly beneficially owned by ZHENG Qingying through MY Universe (HK) Limited and 21,413,276 ordinary shares indirectly beneficially owned by WU Guiqian through Hawyu (HK) Limited. For row 13, the percentage of the class of securities beneficially owned by each Reporting Person is calculated based on 147,326,504 issued and outstanding ordinary shares of the Issuer and 6,423,983 ordinary shares issuable under the warrants granted to Wanda as of the date of this Amendment No. 3 to the Schedule 13D.


SCHEDULE 13D




Comment for Type of Reporting Person:
For rows 8 and 10, represent 36,402,570 ordinary shares indirectly beneficially owned by ZHENG Qingying through MY Universe (HK) Limited and 21,413,276 ordinary shares indirectly beneficially owned by WU Guiqian through Hawyu (HK) Limited. For row 13, the percentage of the class of securities beneficially owned by each Reporting Person is calculated based on 147,326,504 issued and outstanding ordinary shares of the Issuer and 6,423,983 ordinary shares issuable under the warrants granted to Wanda as of the date of this Amendment No. 3 to the Schedule 13D.


SCHEDULE 13D


MY Universe (HK) Limited
Signature:/s/ Wu Binhua
Name/Title:Authorized Representative
Date:04/03/2026
Hainan Oriental Jiechuang Investment Partnership (Limited Partnership)
Signature:/s/ Wu Binhua
Name/Title:Authorized Representative
Date:04/03/2026
Shenzhen Venture Capital M & A Fund Management (Shenzhen) Co., Ltd.
Signature:/s/ Sun Bin
Name/Title:Legal Representative
Date:04/03/2026
Shenzhen Luohu Red Earth Pioneering Cci Capital Ltd
Signature:/s/ Zhang Jian
Name/Title:Legal Representative
Date:04/03/2026
Shenzhen Capital Group Co., Ltd.
Signature:/s/ Zuo Ding
Name/Title:Legal Representative
Date:04/03/2026
Shenzhen Lafang Investment Management Co., Ltd.
Signature:/s/ Wu Binhua
Name/Title:Authorized Representative
Date:04/03/2026
Suqian Beibao Culture Communication Co., Ltd.
Signature:/s/ Wen Guanbo
Name/Title:Legal Representative
Date:04/03/2026
Suqian Baibao Technology Co., Ltd.
Signature:/s/ Jia Wanxing
Name/Title:Legal Representative
Date:04/03/2026
ZHENG Qingying
Signature:/s/ ZHENG Qingying
Name/Title:ZHENG Qingying
Date:04/03/2026
WU Guiqian
Signature:/s/ WU Guiqian
Name/Title:WU Guiqian
Date:04/03/2026

FAQ

What ownership stake is reported in the Aesthetic Medical (PAIYY) Schedule 13D/A Amendment No. 3?

The filing reports that MY Universe (HK) Limited and related entities beneficially own 36,402,570 ordinary shares, equal to 23.7% of the class. This stake is calculated against 147,326,504 issued shares plus 6,423,983 warrant shares as described in the amendment.

How much of Aesthetic Medical (PAIYY) do ZHENG Qingying and WU Guiqian report owning?

ZHENG Qingying and WU Guiqian each report shared beneficial ownership of 57,815,846 ordinary shares, representing 37.6% of the ordinary share class. Their interest arises indirectly through stakes in MY Universe (HK) Limited and Hawyu (HK) Limited, as detailed in the filing.

What major share subscription is described for Aesthetic Medical (PAIYY)?

The document describes a Share Subscription Agreement where Jiechuang or its designee agreed to subscribe for 36,402,570 newly issued ordinary shares of Aesthetic Medical for the U.S. dollar equivalent of RMB170,000,000. These shares were ultimately issued to MY Universe (HK) Limited.

What share purchase transaction involving Wanda is disclosed for Aesthetic Medical (PAIYY)?

Australia Wanda International Company Limited agreed to purchase 21,321,962 ordinary shares of Aesthetic Medical from certain sellers for the U.S. dollar equivalent of RMB100,000,000. The filing states that this share purchase closed, transferring those shares to Wanda.

How many Aesthetic Medical (PAIYY) shares are used to calculate the reported ownership percentages?

Ownership percentages are based on 147,326,504 issued and outstanding ordinary shares of Aesthetic Medical plus 6,423,983 ordinary shares issuable under warrants granted to Wanda. These figures form the denominator for the 23.7% and 37.6% stakes disclosed.

What structural changes to Jiechuang are described in the Aesthetic Medical (PAIYY) filing?

A Subscription Agreement makes Suqian Beibao Culture Communication Co., Ltd. the general partner of Jiechuang, and transfers Lafang Investment’s partnership interest to ZHENG Qingying. A Partnership Withdrawal Agreement also provides for SCGC and SVC Fund Management to withdraw from Jiechuang, with capital returned.